Have a feature idea you'd love to see implemented?
Let us know!
CYRX Cryoport Inc
Price (delayed)
$8.08
Market cap
$399.4M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.39
Enterprise value
$586.61M
Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through
Highlights
The debt has decreased by 44% YoY and by 42% from the previous quarter
The company's net income rose by 8% QoQ
Cryoport's EPS has plunged by 200% YoY but it has increased by 8% from the previous quarter
Cryoport's equity has decreased by 22% YoY but it has increased by 4.6% from the previous quarter
The quick ratio has dropped by 54% year-on-year and by 34% since the previous quarter
CYRX's gross profit is down by 7% year-on-year
Key stats
What are the main financial stats of CYRX
Market
Valuations
Earnings
Shares outstanding
49.43M
Market cap
$399.4M
Enterprise value
$586.61M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.95
Price to sales (P/S)
1.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.59
Revenue
$226.11M
Gross profit
$95.61M
Net income
-$158.47M
EBIT
-$153.8M
EBITDA
-$117.4M
Free cash flow
-$35.14M
Per share
Balance sheet
Liquidity
EPS
-$3.39
EPS diluted
-$3.39
Free cash flow per share
-$0.71
Book value per share
$8.47
Revenue per share
$4.58
TBVPS
$9.55
Total assets
$701.77M
Total liabilities
$283.19M
Debt
$233.37M
Equity
$418.57M
Working capital
$288.9M
Debt to equity
0.56
Current ratio
5.7
Quick ratio
5.17
Net debt/EBITDA
-1.59
Margins
Efficiency
Dividend
EBITDA margin
-51.9%
Gross margin
42.3%
Net margin
-70.1%
Operating margin
-82.6%
Return on assets
-19.3%
Return on equity
-37.4%
Return on invested capital
-17.8%
Return on capital employed
-24%
Return on sales
-68%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CYRX stock price
How has the Cryoport stock price performed over time
Intraday
2.67%
1 week
4.39%
1 month
12.53%
1 year
-49.72%
YTD
-47.84%
QTD
-0.37%
Financial performance
How have Cryoport's revenue and profit performed over time
Revenue
$226.11M
Gross profit
$95.61M
Operating income
-$186.81M
Net income
-$158.47M
Gross margin
42.3%
Net margin
-70.1%
The company's net income rose by 8% QoQ
The net margin has increased by 8% from the previous quarter
CYRX's gross profit is down by 7% year-on-year
The revenue has declined by 4.3% year-on-year
Growth
What is Cryoport's growth rate over time
Valuation
What is Cryoport stock price valuation
P/E
N/A
P/B
0.95
P/S
1.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.59
Cryoport's EPS has plunged by 200% YoY but it has increased by 8% from the previous quarter
CYRX's price to book (P/B) is 75% less than its 5-year quarterly average of 3.7 and 28% less than its last 4 quarters average of 1.3
Cryoport's equity has decreased by 22% YoY but it has increased by 4.6% from the previous quarter
CYRX's P/S is 86% below its 5-year quarterly average of 12.0 and 34% below its last 4 quarters average of 2.6
The revenue has declined by 4.3% year-on-year
Efficiency
How efficient is Cryoport business performance
Cryoport's ROS has increased by 8% from the previous quarter
Dividends
What is CYRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CYRX.
Financial health
How did Cryoport financials performed over time
The total assets is 148% more than the total liabilities
The quick ratio has dropped by 54% year-on-year and by 34% since the previous quarter
The current ratio has plunged by 53% YoY and by 32% from the previous quarter
The debt is 44% less than the equity
The debt to equity has declined by 45% since the previous quarter and by 27% year-on-year
The debt has decreased by 44% YoY and by 42% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.